DaVita (DVA)
(Delayed Data from NYSE)
$163.56 USD
+5.92 (3.76%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $163.58 +0.02 (0.01%) 7:58 PM ET
1-Strong Buy of 5 1
A Value C Growth D Momentum B VGM
Brokerage Reports
DaVita Inc. [DVA]
Reports for Purchase
Showing records 161 - 180 ( 290 total )
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Healthcare Facilities and Services: ACA Repeal and Replace - Lots of Noise, but Risks Appear Modest
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Trimming Estimates on DMG Outlook and Commercial Mix Headwinds
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Trimming Estimates on Further DMG (formerly HCP) Weakness
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Capital Markets Day Highlights ESA Opportunity and Long Turnaround Time at DMG
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Raising Estimates on Better than Expected Kidney Care
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Light Guidance, but Growth Should Improve Beyond 2016
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J